TORONTO, May 04, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc.’s (TSX: ALEF, OTC: ALEAF) (“Aleafia Health ” or the “Company ”) wholly owned subsidiary Emblem Cannabis Corp. (“Emblem ”) has secured a Health Canada Licence Amendment for its Paris Facility’s 30,000 sq. ft. Phase II expansion, entirely dedicated to the extraction, production, packaging and distribution of finished cannabis products.
To read the full press release from Aleafia Health Inc., click here.
This headline brief is meant to help you stay on the pulse of your favorite cannabis-related companies. Sometimes, just figuring out which marijuana stocks may be moving can be one of the toughest parts of trading and investing in them.
Every day, The Daily Marijuana Observer seeks to keep stakeholders informed with as much of the latest news possible to keep you informed of any catalysts that may impact the companies you care about. Be sure to subscribe to cannabis stock updates here, Aleafia Health Inc. Alerts here, and Canadian Licensed Producer Updates here so you never miss an update.
Get Real-Time Updates from MJobserver.com